Back to top
more

Penumbra (PEN)

(Delayed Data from NYSE)

$202.04 USD

202.04
358,121

-2.37 (-1.16%)

Updated Apr 29, 2024 04:00 PM ET

After-Market: $201.98 -0.06 (-0.03%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value A Growth D Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 37% (94 out of 252)

Industry: Medical - Instruments

Better trading starts here.

Zacks News

K2M Group Holdings (KTWO) in Focus: Stock Up 6.3%

K2M Group Holdings, Inc. (KTWO) saw its shares rise above 6% in the last trading session.

    Integra LifeSciences at 52-Week High on Deals, View Update

    Shares of Integra LifeSciences Holdings Corporation (IART), a global leader in medical technology, scaled a new 52-week high of $45.50 on Jan 10, closing a tad lower at $44.90.

      Teleflex Launches LMA Gastro Airway, FDA Okays Arrow VPS

      Teleflex Inc. (TFX) recently announced the launch of LMA Gastro Airway with Cuff Pilot Technology and the receipt of 510(k) approval from the U.S. FDA for its Arrow VPS Rhythm device.

        PerkinElmer (PKI) to Acquire India-Based Tulip Diagnostics

        PerkinElmer, Inc. (PKI) announced that it has entered into a definitive agreement to acquire Tulip Diagnostics Private Ltd.

          Allscripts (MDRX) Q4 Bookings Likely to Hit Record Levels

          Allscripts Healthcare Solutions Inc. (MDRX) recently provided a bullish update on bookings alongside providing a number of financial updates on fourth quarter 2016.

            Air Methods (AIRM): Winter Hits December Passenger Count

            Air Methods Corporation (AIRM), reported tepid preliminary patient transport and tourism passenger data for the month of Dec 2016.

              AngioDynamics (ANGO) Beats Q2 Earnings, Lifts 2017 View

              AngioDynamics Inc. (ANGO) reported adjusted earnings of 19 cents per share in the second quarter of fiscal 2017 beating the Zacks Consensus Estimate by 3 cents.

                Cerner Extends HNM Partnership with University of Missouri

                Cerner Corporation (CERN) and the University of Missouri Health Care announced that they have inked an agreement to extend their partnership.

                  Alere Forensic Toxicology Division Gets ABFT Accreditation

                  Alere Inc. (ALR), a leading player in rapid diagnostic tests, announced that its forensic toxicology division has received accreditation from the American Board of Forensic Toxicology.

                    Luminex (LMNX) Gets FDA Clearance for ARIES GBS Assay

                    Luminex Corporation (LMNX) announced that it has received FDA clearance for the ARIES Group B Streptococcus Assay for antepartum detection of GBS colonization.

                      Mazor Robotics (MZOR) Receives 21 System Orders in Q4

                      Israel-based developer of robotic technology and products, Mazor Robotics Ltd. (MZOR), recently announced the receipt of 21 surgical guidance system orders in fourth-quarter 2016.

                        Cerner Hurt by Low System Sales and Intense Competition

                        On Jan 3, we issued an updated research report on North Kansas City, MO-based Cerner Corporation (CERN).

                          Natus Medical Closes GN Otometrics Business Acquisition

                          Natus Medical Incorporated (BABY) announced the purchase of GN Otometrics from Denmark-based GN Store Nord.

                            Patterson Companies Hurt by Competition & Integration Risks

                            On Jan 3, we issued an updated research report on St. Paul, MN-based Patterson Companies Inc. (PDCO), a leading distributor and seller of dental and animal health products.

                              Indradip Ghosh headshot

                              New Strong Buy Stocks for January 4th

                              Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Wednesday

                                4 Med Instrument Stocks for Q3 Earnings amid Election Chaos

                                The medical device sector is positioned for impressive growth in the near term.